female reproductive system

Interplay of Ovarian and Uterine Cycles

  • There are two cycles in the female reproductive system that are controlled by the same hormones and run in parallel: the ovarian cycle (in the ovaries) and the uterine cycle (in the uterus).

  • For pregnancy, the ovarian cycle must be synchronized with the uterine cycle; if either side is not ready, implantation cannot occur.

  • The speaker emphasizes that the system is highly complex and that many terms are used interchangeably with unclear definitions (e.g., secondary vs. tertiary follicle). The notes below reflect a practical, exam-focused synthesis from the lecture.

Oogenesis and Folliculogenesis: key processes and terminology

  • Oogenesis is the development of an oocyte (egg cell), which is haploid and may be fertilized to form a zygote.

  • Oogonia (germline stem cells) are destined to become eggs/sperm; they undergo mitosis during fetal development and migrate to the ovaries.

  • Germline vs. stem cells distinction:

    • Germline cell: a stem cell that will become an egg or sperm.

    • Stem cell: a general term for cells that can become multiple cell types; germline cells are a subset destined to become eggs or sperm.

  • Fetal development timeline and numbers (not required to memorize, but helpful for context):

    • Around the fifth month of fetal development, oogonia undergo mitosis and migrate; total oogonia ≈ 67imes1066-7 imes 10^6.

    • Birth: total primary oocytes in ovaries ≈ 2imes1062 imes 10^6; each primary oocyte is surrounded by a single layer of flat follicular cells (follicular cells).

    • At puberty, approximately 2imes1052 imes 10^5 primary oocytes remain.

    • About 90% of the initial pool degenerates via atresia during childhood; the pool declines dramatically over time.

  • From birth to puberty (folliculogenesis begins):

    • Primordial follicles: single layer of squamous follicular cells around the oocyte.

    • Primary follicles: flat cells proliferate and become cuboidal; granulosa cells appear as the follicle enlarges.

    • Thecal cells appear later (theca interna and externa), enabling production of androgen precursors.

    • Zona pellucida forms around the oocyte (a gelatinous extracellular matrix).

  • Transition to more mature follicles:

    • Primary follicle → secondary follicle: granulosa cells proliferate into multiple layers; theca cells organize around the follicle; estrogen production begins, primarily estrogen via granulosa cells.

    • The granulosa cells secrete estrogen; the theca cells produce androgen precursors that granulosa cells convert to estrogen (estradiol, the most potent estrogen).

    • The cell types: granulosa cells (follicular cells that become multilayered) and theca cells (outer layer) support follicle growth and hormone production.

  • Antrum and antral follicles:

    • As the follicle grows, granulosa cells secrete follicular fluid, forming an antrum (visible as a fluid-filled cavity under the microscope).

    • Antral follicles are also called secondary follicles early in the process; larger antral follicles with a prominent cavity may be called tertiary follicles.

    • Antrum presence marks the antral stage; when the antrum is large and fluid-filled, the follicle is typically called an antral/tertiary follicle.

  • Cumulus oophorus and corona radiata:

    • The oocyte is surrounded by cumulus granulosa cells (cumulus oophorus) and then by the corona radiata (outermost layer) just before ovulation.

  • Follicle maturation and selection:

    • Many follicles begin development each cycle, but only one becomes the dominant (ovulatory) follicle.

    • The dominant antral follicle becomes the mature follicle that will ovulate an oocyte; other follicles undergo atresia.

    • The selection process involves a positive feedback loop where the most advanced follicle with the highest receptor sensitivity to gonadotropins accumulates receptors and outcompetes others.

  • Meiosis and oocyte maturation:

    • Oogenesis yields primary oocytes arrested in Prophase I at birth; they resume meiosis during follicular maturation.

    • After recruitment to the cohort, meiosis I completes to form a secondary oocyte and a first polar body.

    • The secondary oocyte begins meiosis II and is arrested at Metaphase II until fertilization.

    • If fertilization occurs, meiosis II completes, producing a second polar body and an ovum; if not fertilized, the secondary oocyte degenerates.

  • The mature (ovulatory) follicle release (ovulation):

    • Ovulation is the rupture of the mature follicle, releasing the secondary oocyte surrounded by surrounding granulosa cells (corona radiata).

    • The follicle wall ruptures, and the oocyte with corona radiata is swept into the fallopian tube by fimbriae.

    • The remaining follicle tissue becomes the corpus luteum.

  • The corpus luteum and its fate:

    • The corpus luteum forms from the remnants of the follicle after ovulation and secretes progesterone (and estrogen) and inhibin.

    • Progesterone supports the endometrium and prepares the uterus for implantation; inhibin provides negative feedback on FSH.

    • If no fertilization occurs, the corpus luteum degenerates after about 12 days into a fibrous scar-like structure called corpus albicans, progesterone and estrogen drop, and the next cycle begins (GnRH resumes, FSH/LH rise, follicular development restarts).

    • If fertilization occurs, human chorionic gonadotropin (hCG) from the implanted embryo rescues the corpus luteum to continue progesterone support until the placenta takes over (around the end of the first trimester).

  • Hormonal interplay during folliculogenesis and ovulation:

    • Follicle-stimulating hormone (FSH) from the anterior pituitary stimulates follicle growth and granulosa cell estrogen production; granulosa cells secrete inhibin which provides negative feedback on FSH.

    • Luteinizing hormone (LH) from the anterior pituitary stimulates theca cells to produce androgen precursors, which granulosa cells convert to estrogen (primarily estradiol, extE2ext{E}_{2}).

    • Estradiol (estrogen) has a dual role: at low levels it exerts negative feedback on the pituitary to limit FSH/LH; at higher levels it participates in the positive feedback that triggers the mid-cycle LH surge.

    • Inhibin produced by granulosa cells provides negative feedback on FSH specifically.

    • The rising estrogen also stimulates endometrial proliferation in the uterus (proliferative phase) and prepares for potential implantation.

    • Progesterone, produced by the corpus luteum after ovulation, shifts the endometrium to a secretory state and provides negative feedback to GnRH to limit new follicle recruitment during the luteal phase.

  • Important note on timing and terminology:

    • Early follicular development is sometimes labeled as primordial → primary → secondary with granulosa cells and theca cells evolving; the exact cutoffs between secondary and tertiary follicles are not strictly standardized in all textbooks.

    • Antrum presence marks the antral stage; a very large antrum defines a more mature (tertiary) antral follicle.

    • The oocyte released at ovulation is a secondary oocyte, which will complete meiosis II only if fertilized.

  • Real-world relevance and clinical context:

    • Ovulation is a finely tuned event with a hormonal surge (LH) that is essential for releasing the oocyte.

    • The corpus luteum’s hormone production is crucial for maintaining the endometrium; without pregnancy, its regression leads to menses.

    • Fertility treatments (e.g., Clomid) manipulate the hypothalamic-pituitary-ovarian axis to increase the number of follicles that mature and potentially be ovulated, increasing the chance of pregnancy but raising the risk of multiple gestations.

Hormonal Regulation: GnRH, FSH, LH, Estrogen, Progesterone, and Inhibin

  • Hypothalamic-pituitary-ovarian axis:

    • GnRH (gonadotropin-releasing hormone) from the hypothalamus stimulates the anterior pituitary to secrete two gonadotropins: FSH and LH.

    • FSH stands for follicle-stimulating hormone; LH stands for luteinizing hormone.

    • The pattern of GnRH release is pulsatile and varies across the cycle in females.

  • Follicular phase (roughly days 1–14 of a 28-day cycle):

    • FSH stimulates growth of a cohort of follicles (primary → secondary → antral); granulosa cells secrete estrogens (primarily estradiol, extE2ext{E}_{2}).

    • The rising estrogen levels provide negative feedback on FSH but eventually, high estrogen from the growing dominant follicle turns into a positive feedback that triggers the LH surge near mid-cycle.

    • Inhibin is secreted by granulosa cells and inhibits FSH to limit further follicle recruitment.

    • Endometrium begins proliferative thickening under estrogen influence.

  • Mid-cycle and ovulation:

    • The LH surge triggers ovulation (rupture of the dominant follicle) and formation of the corpus luteum.

    • After ovulation, the oocyte is released with corona radiata into the fallopian tube.

  • Luteal phase (roughly days 14–28):

    • The corpus luteum secretes progesterone (dominant hormone in this phase) and estrogen; inhibin is also secreted.

    • Progesterone promotes endometrial secretory transformation (glycogen and secretions) to support implantation and pregnancy; it also helps dampen GnRH to prevent simultaneous recruitment of new follicle cohorts.

    • If fertilization does not occur, the corpus luteum degenerates (after ~12 days), progesterone and estrogen fall, and the endometrium sheds (menses); GnRH, FSH, and LH rise again to start a new cycle.

  • If pregnancy occurs:

    • hCG from the developing embryo rescues the corpus luteum, maintaining progesterone (and estrogen) production through the first trimester until placental takeover.

The Ovarian Cycle: Phases, Timing, and Key Events

  • Timeline overview (conventional 28-day view; real cycles vary):

    • Day 1: Menstrual bleeding begins as the endometrium sheds (loss of the functional layer, stratum functionalis).

    • Days 1–14 (Follicular phase): Follicles recruit and mature; estrogen rises; endometrium proliferates.

    • Day ~14 (Ovulation): Dominant follicle ruptures; oocyte released with corona radiata; fimbriae sweep it into the fallopian tube.

    • Days 14–28 (Luteal phase): Corpus luteum forms and secretes progesterone and estrogen; endometrium becomes secretory.

    • If no fertilization: corpus luteum degenerates; endometrium sheds; cycle restarts.

  • Key concepts: dominance and selection, timing of meiosis, and the shift from estrogen to progesterone dominance around ovulation.

  • Important nuances addressed in the lecture:

    • Ovulation occurs regardless of fertilization; pregnancy prevents further ovulation by maintaining progesterone via the corpus luteum (or placental hormone support) and suppressing GnRH.

    • The actual biology spans much longer developmental windows (oocytes begin development long before puberty) than the simplified 28-day cycle suggests; however, for teaching and exam purposes the condensed 28-day model is used.

The Uterine Cycle: Endometrium Changes Across the Cycle

  • Endometrium anatomy:

    • Stratum functionalis: the functional layer that thickens and sheds during menses.

    • Stratum basalis: deeper layer that regenerates the functionalis after each cycle.

  • Hormonal control and endometrial changes:

    • Estrogen (dominant in the first half) stimulates thickening and proliferation of the endometrium and growth of glands.

    • Progesterone (dominant in the second half, post-ovulation) promotes secretory transformation of the endometrium; glands secrete glycogen-rich secretions to prepare for implantation.

    • If implantation does not occur, progesterone and estrogen fall, leading to ischemia and shedding of the functional layer (menses).

  • Relationship to cervical mucus and fertility:

    • Estrogen-rich first half: cervical mucus becomes more permissive to sperm transport.

    • After ovulation, progesterone causes mucus to become thicker and less penetrable, reducing sperm passage—part of the window for implantation.

  • Practical takeaway:

    • The uterine cycle responds to ovarian hormones to prepare a receptive environment; menstruation occurs if there is no implantation, not simply because ovulation happened.

Fertilization, Pregnancy, and the Ovarian-Uterine Axis

  • Fertilization typically occurs in the fallopian tube; the zygote travels to the uterus for implantation in the receptive endometrium.

  • Pregnancy-related hormonal changes:

    • If fertilization and implantation occur, placental hormones (including hCG) maintain the corpus luteum to sustain progesterone production in early pregnancy.

    • The placenta then takes over progesterone and estrogen production as pregnancy progresses.

  • Non-pregnant cycle: cycle resets after corpus luteum regression and loss of progesterone support, leading to menses and new follicular recruitment.

Case Study: Clomid and Angela’s Scenario

  • Angela’s story (a 26-year-old with irregular cycles after stopping birth control and trying to conceive):

    • Clomid (clomiphene citrate) is discussed as a fertility drug used to stimulate ovulation.

    • Mechanism of Clomid:

    • Clomid acts as a selective estrogen receptor modulator (SERM) that competes with estrogen at central receptors, effectively blocking estrogen feedback at the hypothalamus/pituitary.

    • This reduces negative feedback, increasing GnRH pulse frequency and amplitude, which raises FSH and LH release from the pituitary.

    • The net effect is enhanced follicular recruitment and maturation, increasing the likelihood of ovulation.

    • Clinical considerations:

    • Clomid can lead to multiple mature follicles and therefore increases the risk of multiple pregnancies (e.g., fraternal twins, occasionally higher-order multiples).

    • The drug’s action is centered on the hypothalamic-pituitary-ovarian axis; it indirectly influences cervical mucus and endometrial environment via altered estrogen/FSH/LH dynamics.

    • Practical timeline and dosing (from the lecture): Clomid is often prescribed for days 5–9 of the cycle to maximize follicular stimulation.

  • Additional discussion points from the case:

    • The role of synthetic birth control pills (ethinyl estradiol + progestin) in suppressing the hypothalamic-pituitary-ovarian axis and thickening cervical mucus.

    • Differences between contraception and fertility treatment in terms of hormonal feedback and cycle regulation.

    • The potential for Clomid to alter the timing and number of maturating follicles and the downstream implications for pregnancy outcomes.

Quick Practice Points for Exam Preparation

  • Dominant hormones by cycle phase:

    • First half (follicular phase): estrogen (estradiol) predominates; FSH drives follicle growth; estrogen rises and initially provides negative feedback on LH, then triggers LH surge.

    • Second half (luteal phase): progesterone predominates (from the corpus luteum); estrogen remains present; progesterone supports endometrium and prevents new follicle recruitment.

  • Key cycle events to know:

    • LH surge triggers ovulation and corpus luteum formation.

    • Corpus luteum secretes progesterone, estrogen, and inhibin; progesterone supports the secretory endometrium.

    • If no pregnancy: corpus luteum degenerates; hormone levels fall; endometrium sheds (menstruation).

    • If pregnancy: hCG rescues corpus luteum until placental takeover (roughly by the end of the first trimester).

  • Important terminology to be comfortable with:

    • Follicles: primordial → primary → secondary → antral (tertiary) → dominant/ovulatory follicle.

    • Oocyte stages: primary oocyte (diploid, arrested in Prophase I at birth), secondary oocyte (haploid, arrested in Metaphase II until fertilization).

    • Supporting cells: granulosa cells (multilayer around oocyte; estrogen production), theca cells (androgen precursors; stimulated by LH).

    • Fluid-filled structures: antrum within the follicle; corona radiata and cumulus oophorus around the oocyte.

    • Endometrium layers: stratum functionalis (shed during menses) and stratum basalis (rebuilds functionalis).

Quick Glossary (selected terms)

  • GnRH: Gonadotropin-releasing hormone from the hypothalamus that stimulates the pituitary to release FSH and LH.

  • FSH: Follicle-stimulating hormone; stimulates follicle growth and estrogen production by granulosa cells.

  • LH: Luteinizing hormone; stimulates theca cells to produce androgens, triggering ovulation and corpus luteum formation.

  • Estrogen (estradiol, E2): Primary ovarian estrogen; promotes follicle growth and endometrial proliferation; high levels trigger LH surge.

  • Inhibin: Hormone from granulosa cells that inhibits FSH secretion.

  • Progesterone: Hormone from the corpus luteum; promotes endometrial secretory changes; supports pregnancy if fertilization occurs.

  • Corpus luteum: Remnant of the follicle after ovulation; secretes progesterone and estrogen; degenerates if no pregnancy.

  • Corpus albicans: The scar-like remnant of the corpus luteum after it degenerates.

  • hCG: Human chorionic gonadotropin; rescues the corpus luteum during early pregnancy.

  • Zona pellucida: Glycoprotein layer surrounding the oocyte.

  • Corona radiata: Layer of granulosa cells immediately surrounding the oocyte after ovulation.

  • Menses (menstruation): Shedding of the stratum functionalis when there is no implantation.

Note: The lecture emphasizes that real human cycles can vary in length and phase timing (e.g., 20–45 days) and that educational materials often present a simplified 28-day model for clarity. The core concepts—hormonal regulation, follicle development, ovulation, corpus luteum function, and uterine preparation—remain consistent across sources.